About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristant #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Enter your email address:

Delivered by FeedBurner

Contact the Docs

Docs on Twitter


Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Renova Therapeutics Begins Congestive Heart Failure Gene Therapy Trials | Main | Reaction to Senate Patent Reform Bill (S. 23) »

February 08, 2011

Comments

Let me ask you guys a question. Why, do you reckon, did congress never pass a law specifically to promote the medicinal arts? I mean, just as a general matter, for all these centuries to have gone by and them to never thought of it seems silly to me. Was there never any lobbyists promoting a patent act, or something comparable, for the medicinal arts? Anyone with any historical knowledge on the subject? Especially on the time around 1800-1920?

Did congress not feel that it would benefit the medicinal arts to have such an act in place? Did they simply never think to do it?

Perhaps doctors never btched and whined about protecting their industry with such a tool, as artisans in the useful arts did, back in the day? Perhaps congress felt it would be unethical?

Surely the topic must have been raised at some point.

The patent office has issued supplementary guidelines for examining claims in patent applications for compliance with 35 U.S.C. §112 ¶2. The PTO thinks "it is of utmost importance that patents issue with definite claims that clearly and precisely inform persons skilled in the art of the boundaries of protected subject matter." The guidelines are effective as of today. Written comments are accepted until April 11, 2011. "No public hearing will be held."

The comments to this entry are closed.

March 2019

Sun Mon Tue Wed Thu Fri Sat
          1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31